Constant currency growth Value creation Simplified manufacturing footprint Market dynamics Gross margin Shareholder value / maximizing shareholder value UroLift Sequential improvement Constant currency basis Strategic update / strategy Guiding principles Year- over-year growth Cost inflation Core business Potential sale of Newco NewCo Focused strategic direction Tariff impact / tariffs Operating margin Parallel paths Operational excellence / operational execution Acquisition (Vascular Intervention acquisition) Revenue / revenue growth / revenues Volume- based procurement Integration activities / integration Cash flow from operations Long- term growth Future outlook FreeSolve technology Adjusted earnings per share In line with expectations Interventional business Titan SGS stapler Barrigel Unlock value Guidance / updated financial guidance Strategic rationale Better than expected Expressions of interest Patient outcomes / patient care Spin Foreign exchange impact Clinical data Capital allocation strategy Investor event Constant currency growth Value creation Simplified manufacturing footprint Market dynamics Gross margin Shareholder value / maximizing shareholder value UroLift Sequential improvement Constant currency basis Strategic update / strategy Guiding principles Year- over-year growth Cost inflation Core business Potential sale of Newco NewCo Focused strategic direction Tariff impact / tariffs Operating margin Parallel paths Operational excellence / operational execution Acquisition (Vascular Intervention acquisition) Revenue / revenue growth / revenues Volume- based procurement Integration activities / integration Cash flow from operations Long- term growth Future outlook FreeSolve technology Adjusted earnings per share In line with expectations Interventional business Titan SGS stapler Barrigel Unlock value Guidance / updated financial guidance Strategic rationale Better than expected Expressions of interest Patient outcomes / patient care Spin Foreign exchange impact Clinical data Capital allocation strategy Investor event
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Constant currency growth
Value creation
Simplified manufacturing footprint
Market dynamics
Gross margin
Shareholder value / maximizing shareholder value
UroLift
Sequential improvement
Constant currency basis
Strategic update / strategy
Guiding principles
Year-over-year growth
Cost inflation
Core business
Potential sale of Newco
NewCo
Focused strategic direction
Tariff impact / tariffs
Operating margin
Parallel paths
Operational excellence / operational execution
Acquisition (Vascular Intervention acquisition)
Revenue / revenue growth / revenues
Volume-based procurement
Integration activities / integration
Cash flow from operations
Long-term growth
Future outlook
FreeSolve technology
Adjusted earnings per share
In line with expectations
Interventional business
Titan SGS stapler
Barrigel
Unlock value
Guidance / updated financial guidance
Strategic rationale
Better than expected
Expressions of interest
Patient outcomes / patient care
Spin
Foreign exchange impact
Clinical data
Capital allocation strategy
Investor event